CVS Group plc (CVSG) To Go Ex-Dividend on October 31st

CVS Group plc (LON:CVSGGet Free Report) announced a dividend on Thursday, September 26th, Upcoming.Co.Uk reports. Shareholders of record on Thursday, October 31st will be given a dividend of GBX 8 ($0.11) per share on Friday, November 29th. This represents a yield of 0.71%. The ex-dividend date is Thursday, October 31st. This is a boost from CVS Group’s previous dividend of $7.50. The official announcement can be seen at this link.

CVS Group Trading Down 5.4 %

LON:CVSG opened at GBX 1,112 ($14.89) on Friday. CVS Group has a 1 year low of GBX 902.41 ($12.08) and a 1 year high of GBX 1,749 ($23.42). The stock has a market cap of £797.08 million, a P/E ratio of 2,224.00, a P/E/G ratio of 1.77 and a beta of 1.02. The company has a debt-to-equity ratio of 100.75, a quick ratio of 0.90 and a current ratio of 1.15. The stock has a 50-day simple moving average of GBX 1,113.31 and a 200-day simple moving average of GBX 1,052.94.

Insider Activity at CVS Group

In other news, insider Richard Gray purchased 1,600 shares of the business’s stock in a transaction on Wednesday, July 10th. The shares were bought at an average price of GBX 1,019 ($13.64) per share, with a total value of £16,304 ($21,831.82). 1.45% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 2,370 ($31.74) price target on shares of CVS Group in a research note on Thursday, July 25th.

View Our Latest Report on CVS Group

CVS Group Company Profile

(Get Free Report)

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.

See Also

Dividend History for CVS Group (LON:CVSG)

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.